SARS-CoV-2 Spike Does Not Possess Intrinsic Superantigen-like Inflammatory Activity

Area of Science:

• Immunology
• Virology
• Molecular Biology

Background:

• Multisystem Inflammatory Syndrome in Children (MIS-C) is a rare hyperinflammatory condition following SARS-CoV-2 infection.
• Clinical parallels with toxic shock syndrome and T-cell receptor (TCRVβ) skewing suggested a superantigen mechanism for MIS-C.
• In silico analysis indicated a potential superantigenic motif in the SARS-CoV-2 spike protein, similar to staphylococcal enterotoxin B (SEB).

Purpose of the Study:

• To experimentally investigate the superantigenic activity of the SARS-CoV-2 spike protein.
• To compare the inflammatory cytokine production induced by the SARS-CoV-2 spike protein versus a known superantigen (SEB).

Main Methods:

• Assessed superantigenic activity by analyzing inflammatory cytokine production.
• Utilized Jurkat cells and peripheral blood CD4+ T cells.
• Stimulated cells with either the SARS-CoV-2 spike protein or SEB as a control.

Main Results:

• The SARS-CoV-2 spike protein did not induce inflammatory cytokine production in stimulated cells.
• SEB, used as a positive control, demonstrated superantigenic activity.
• No intrinsic superantigen-like activity was detected for the SARS-CoV-2 spike protein.

Conclusions:

• The SARS-CoV-2 spike protein does not possess intrinsic superantigen-like activity.
• This finding challenges the superantigen theory for the pathogenesis of MIS-C.
• Further research is needed to elucidate the mechanisms underlying MIS-C.